CHINA HEALTHWISE HOLDINGS LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.048 HKD | 0.00% |
|
-11.11% | +17.07% |
| Mar. 26 | China Healthwise Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Mar. 21 | China Healthwise to Widen Losses in 2023 | MT |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 519.8 | 282.4 | 177.2 | 215.7 | 145.6 | 31.59 |
| Enterprise Value (EV) 1 | 496.5 | 254.7 | 145.8 | 205 | 176.8 | 81.33 |
| P/E ratio | -2.26 x | -1.76 x | -7.07 x | -2.09 x | -2.68 x | -0.23 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 0.76 x | 0.68 x | 1.29 x | 1.27 x | 1.03 x | 0.22 x |
| EV / Revenue | 0.73 x | 0.62 x | 1.06 x | 1.21 x | 1.24 x | 0.56 x |
| EV / EBITDA | -7.23 x | -15.6 x | -2.87 x | -2.72 x | -4.63 x | -0.72 x |
| EV / FCF | -13.4 x | -1.7 x | 1.63 x | 125 x | -1.56 x | 1.9 x |
| FCF Yield | -7.45% | -58.9% | 61.3% | 0.8% | -64.1% | 52.5% |
| Price to Book | 1.32 x | 0.87 x | 0.6 x | 1.12 x | 1.05 x | 7.18 x |
| Nbr of stocks (in thousands) | 852,131 | 784,441 | 770,481 | 770,481 | 770,481 | 770,481 |
| Reference price 2 | 0.6100 | 0.3600 | 0.2300 | 0.2800 | 0.1890 | 0.0410 |
| Announcement Date | 7/27/18 | 4/28/20 | 4/21/21 | 4/28/22 | 4/26/23 | 4/25/24 |
1HKD in Million2HKD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 682.5 | 413.3 | 137.9 | 170.1 | 142.1 | 146.3 |
| EBITDA 1 | -68.67 | -16.34 | -50.75 | -75.48 | -38.2 | -112.2 |
| EBIT 1 | -88.73 | -18.05 | -52.31 | -75.78 | -38.39 | -112.6 |
| Operating Margin | -13% | -4.37% | -37.94% | -44.56% | -27.02% | -76.94% |
| Earnings before Tax (EBT) 1 | -194.7 | -168.4 | -72.93 | -100.6 | -56.4 | -132.1 |
| Net income 1 | -186.1 | -165.8 | -25.22 | -103 | -54.27 | -134.6 |
| Net margin | -27.27% | -40.12% | -18.3% | -60.59% | -38.21% | -91.96% |
| EPS 2 | -0.2694 | -0.2045 | -0.0325 | -0.1337 | -0.0704 | -0.1746 |
| Free Cash Flow 1 | -37 | -150.1 | 89.43 | 1.64 | -113.4 | 42.69 |
| FCF margin | -5.42% | -36.33% | 64.88% | 0.96% | -79.8% | 29.18% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 7/27/18 | 4/28/20 | 4/21/21 | 4/28/22 | 4/26/23 | 4/25/24 |
1HKD in Million2HKD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | 31.2 | 49.7 |
| Net Cash position 1 | 23.3 | 27.7 | 31.4 | 10.8 | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | -0.8159 x | -0.4433 x |
| Free Cash Flow 1 | -37 | -150 | 89.4 | 1.64 | -113 | 42.7 |
| ROE (net income / shareholders' equity) | -70.1% | -20.9% | -22.2% | -42.1% | -32.7% | -188% |
| ROA (Net income/ Total Assets) | -9.62% | -0.76% | -6.33% | -12.7% | -7.97% | -32.2% |
| Assets 1 | 1,934 | 21,783 | 398.4 | 814.1 | 680.7 | 418.2 |
| Book Value Per Share 2 | 0.4600 | 0.4200 | 0.3800 | 0.2500 | 0.1800 | 0.0100 |
| Cash Flow per Share 2 | 0.0800 | 0.0600 | 0.0500 | 0.0500 | 0.0200 | 0.0200 |
| Capex 1 | 6.31 | 4.36 | 4.52 | 0.36 | 0.63 | 0.19 |
| Capex / Sales | 0.92% | 1.06% | 3.28% | 0.21% | 0.44% | 0.13% |
| Announcement Date | 7/27/18 | 4/28/20 | 4/21/21 | 4/28/22 | 4/26/23 | 4/25/24 |
1HKD in Million2HKD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| +17.07% | 4.73M | |
| +26.77% | 76.29B | |
| -2.27% | 23.99B | |
| +10.27% | 9.01B | |
| +12.25% | 8.67B | |
| -24.34% | 7.58B | |
| +12.70% | 5.18B | |
| +2.89% | 4.16B | |
| -4.96% | 3.98B | |
| -1.36% | 3.63B |
- Stock Market
- Equities
- 348 Stock
- Financials China Healthwise Holdings Limited
